Ovarian stimulation using a new highly purified urinary FSH: A prospective randomized clinical study

Clinical and Experimental Obstetrics and Gynecology

Volumn 26, Issue 2, 1999, Pages 93-94

  Gerli, S ^a   Perino, M ^b   Abate, A ^b   Costabile, L ^c,d   Gholami, H ^c   Vitiello, L ^c  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Papardo Hospital   (Italy)

^c Association for Infertility Studies   (Italy)

^d NONE   (Italy)

Author keywords

Effectiveness; Fostimon; FSH; Metrodin HP

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; GONASI; UNCLASSIFIED DRUG; UROFOLLITROPIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOPRESERVATION; DRUG SAFETY; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; OOCYTE; OVARY FUNCTION; PREGNANCY RATE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032995070     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. nd World Conference on ovulation induction. Bologna, 12-13 September. 1997.
2. th Congresso Mundial de fertilidad e estemidad. Madrid, 1980, abstract 358.
3. Bentick B., Shaw R. W., Iffland C. A., Burford G., Bernard A.: "A randomized comparative study of purified FSH and hMG after pituitary desensitization with buserelin for superovulation and IVF". Fertil. Steril., 1988. 50, 89.
4. Tanbo T., Dale P., Haug E., Abyolm T., Kjeskshus E.: "Stimulation with human menopausal gonadotrophin versus follicle stimulating hormone after pituitary suppression polycystic ovarian syndrome" Fertil. Steril., 1990, 53, 798.